Arai M, Okuno F, Ishii H, Hirano Y, Sujita K, Kobayashi T, Takagi T, Maruyama K, Kato S, Tsugu M
Nihon Shokakibyo Gakkai Zasshi. 1989 Feb;86(2):220-6.
Recently, hepatic microcirculation has been focused on as an important pathogenic factor in progression of alcoholic liver disease (ALD). Therefore, blood levels of several prostaglandins, which are associated with organ microcirculation, were determined in various liver diseases, including ALD. Blood thromboxane B2 (TXB2) level was significantly increased in ALD, when compared to other types of liver diseases, whereas both 6-keto prostaglandin F1 alpha (6-keto PGF1 alpha) and prostaglandin E were not changed. These consequences resulted in the imbalance of 6-keto PGF1 alpha to TXB2, which might promote platelet aggregation and blood vessel contraction. Indeed, the increase of beta-thromboglobulin and platelet factor 4 in blood was observed in ALD. Furthermore, in ALD, the rate of arachidonate-induced platelet aggregation was prominently enhanced, and malondialdehyde production in platelet, which was well correlated with blood TXB2 levels, significantly increased. Thus, the present study may indicate that, in ALD, hyper-aggregability of platelet is produced, because of the derangement of prostaglandin metabolism and platelet dysfunction.
最近,肝微循环作为酒精性肝病(ALD)进展中的一个重要致病因素受到关注。因此,在包括ALD在内的各种肝病中,测定了与器官微循环相关的几种前列腺素的血药浓度。与其他类型的肝病相比,ALD患者血中血栓素B2(TXB2)水平显著升高,而6-酮前列腺素F1α(6-酮PGF1α)和前列腺素E均无变化。这些结果导致6-酮PGF1α与TXB2失衡,这可能促进血小板聚集和血管收缩。事实上,在ALD患者中观察到血液中β-血小板球蛋白和血小板因子4增加。此外,在ALD患者中,花生四烯酸诱导的血小板聚集率显著增强,且血小板中丙二醛的产生与血TXB2水平密切相关,显著增加。因此,本研究可能表明,在ALD中,由于前列腺素代谢紊乱和血小板功能障碍,导致血小板高聚集性。